Abstract
Disturbed sleep is closely associated with an increased risk of metabolic diseases. However, the underlying mechanisms of circadian clock genes linking sleep and lipid profile abnormalities have not been fully elucidated. This study aimed to explore the important role of the circadian clock in regulating impaired cholesterol metabolism at an early stage of sleep deprivation (SD). Sleep disturbance was conducted using an SD instrument. Our results showed that SD increased the serum cholesterol levels. Concentrations of serum leptin and resistin were much lower after SD, but other metabolic hormone concentrations (adiponectin, glucagon, insulin, thyroxine, norepinephrine, and epinephrine) were unchanged before and after SD. Warning signs of cardiovascular diseases [decreased high density lipoprotein (HDL)-cholesterol and increased corticosterone and 8-hydroxyguanosine levels] and hepatic cholestasis (elevated total bile acids and bilirubin levels) were observed after SD. Cholesterol accumulation was also observed in the liver after SD. The expression levels of HMGCR, the critical enzyme for cholesterol synthesis, remained unchanged in the liver. However, the expression levels of liver CYP7A1, the enzyme responsible for the conversion of cholesterol into bile acids, significantly reduced after SD. Furthermore, expression of NR1D1, a circadian oscillator and transcriptional regulator of CYP7A1, strikingly decreased after SD. Moreover, NR1D1 deficiency decreased liver CYP7A1 levels, and SD could exacerbate the reduction of CYP7A1 expression in NR1D1−/− mouse livers. Additionally, NR1D1 deficiency could further increase serum cholesterol levels under SD. These results suggest that sleep disturbance can induce increased serum cholesterol levels and liver cholesterol accumulation by NR1D1 mediated CYP7A1 inhibition.
Highlights
Maintenance of sleep homoeostasis regulated by the homoeostatic and circadian process plays important roles in the balance of psychological and physical health (Saper et al, 2005; Kon et al, 2017)
The results showed that expression levels of farnesoid-X-receptor (FXR), retinoid X receptor alpha (RXRa), liver receptor homolog 1 (LRH1), hepatocyte nuclear receptor 4 alpha (HNF4a), CCAAT enhancer binding protein α (C/EBPa), and forkhead box O1 (FOXO1) at transcription level were not strikingly affected by sleep deprivation (SD) (Figure 4C)
Considering the early metabolic alterations caused by sleep disturbance, our results showed that a high cholesterol level in serum lipid profiles was rapidly induced by sleep deprivation exposure (24 and 72 h) in both rat and mice
Summary
Maintenance of sleep homoeostasis regulated by the homoeostatic and circadian process plays important roles in the balance of psychological and physical health (Saper et al, 2005; Kon et al, 2017). Numerous epidemiological studies have suggested that adverse effects of sleep loss are closely associated with increased risk of obesity, type 2 diabetes, and cardiovascular diseases (CVDs; Reutrakul and Van Cauter, 2018; Liu and Chen, 2019). The association of metabolic disorders with sleep loss caused by total sleep deprivation (SD), chronic sleep restriction, or sleep fragmentation has gained attention (Killick et al, 2012; Nedeltcheva and Scheer, 2014). It has been suggested that the development of metabolic disorders or CVDs may be associated with long term or immediate effects of sleep loss or disruption. It is important to explore the potential mechanism underlying this association
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.